Clinical Trials on Triple Negative Breast Cancer (Part F)
Total 1234 results
-
Kari WisinskiNovartis; University of Wisconsin, Madison; Big Ten Cancer Research ConsortiumRecruiting
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
Hebei Medical University Fourth HospitalBeijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.UnknownTriple Negative Breast Cancer | Nab-paclitaxelChina
-
Luz A. Venta, MDCompletedBreast Cancer | Triple Negative Breast Cancer | Emotions | ImmunologyUnited States
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...RecruitingTriple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)United States
-
Xiang ZhangMirati Therapeutics Inc.TerminatedBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity IncActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Early-stage Breast CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Hormone Receptor-Negative Breast CarcinomaUnited States
-
West German Study GroupMerck Sharp & Dohme LLC; Gilead SciencesNot yet recruiting
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, United Kingdom, Korea, Republic of, Philippines, Canada, Germany, Italy, Poland, Belgium, Mexico, Japan, France, Brazil, Taiwan, Thailand, Hungary, Turkey, China, India, South Africa, Singapore, Argentina
-
University College Hospital, IbadanUniversity of Chicago; Lagos State University; Obafemi Awolowo University Teaching... and other collaboratorsRecruiting
-
Institut Cancerologie de l'OuestSIRIC ILIADCompletedTriple Negative Breast CancerFrance
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
Merck Sharp & Dohme LLCCompleted
-
GTxTerminatedTriple Negative Breast CancerUnited States
-
Xiaoming XieUnknown
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
European Institute of OncologyRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Neoadjuvant ChemotherapyItaly
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
National Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingBreast Cancer | Triple Negative Breast Cancer | Cardiovascular ComplicationsUnited States
-
St Vincent's Hospital, SydneyRecruitingTriple Negative Breast CancerAustralia
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
Bryan Schneider, MDHoosier Cancer Research Network; Walther Cancer Institute; Vera Bradley Foundation... and other collaboratorsCompletedBreast Cancer | Malignant Neoplasm of BreastUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Milton S. Hershey Medical CenterRecruitingBreast Cancer | Contrast Enhanced UltrasoundUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Federico II University; Humanitas Clinical and Research Center; Istituto Oncologico... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast Cancer | Fasting | Dietary ExposureItaly
-
Duke UniversityAstraZenecaCompletedTriple Negative Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...UnknownSystematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast CancerChina
-
Institute of Cancer Research, United KingdomCase45 LtdNot yet recruitingTriple Negative Breast Cancer
-
Genexine, Inc.Merck Sharp & Dohme LLCCompletedTriple Negative Breast CancerKorea, Republic of
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
Washington University School of MedicineTerminatedNeoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast CancerBreast NeoplasmsUnited States
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
-
The Netherlands Cancer InstituteNot yet recruitingAvoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
-
Kathy MillerPfizer; Astex Pharmaceuticals, Inc.; Van Andel Institute Stand Up to Cancer TeamCompletedMetastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly
-
HutchmedActive, not recruitingRectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Breast Cancer FoundationRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Immune Checkpoint InhibitorKorea, Republic of
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
TransThera Sciences (Nanjing), Inc.Active, not recruitingAdvanced Solid Tumors | Triple Negative Breast CancerUnited States, China